WASHINGTON – Legal fights over the Trump administration's proposed $1.776 billion "anti-weaponization fund" are continuing, after acting Attorney General Todd Blanche said the Justice Department won't ...

The Justice Department told two federal judges on Friday that cases challenging President Donald Trump’s “anti-weaponization fund” are moot because the administration has abandoned the program. The ...

The U.S. Marine Corps honored the legacy of the AV-8B Harrier II and the Marines who served with it in a ‘Sundown Ceremony’ at MCAS Cherry Point, home to the type’s last operational unit. The U.S.

The 2nd Marine Aircraft Wing bid farewell to the AV-8B Harrier II in a “Sundown Ceremony” Wednesday at Marine Corps Air Station Cherry Point in North Carolina. The Harrier jump jet was in service for ...

WASHINGTON (AP) — The Trump administration is scrapping plans for a $1.8 billion fund that would have compensated allies of the Republican president, the Justice Department’s top official said Tuesday ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. U.S. Marine Corps AV-8B Harrier II aircraft with Marine Attack Squadron (VMA) 223, Marine ...

A federal judge in Florida agreed to reopen President Trump’s bid to sue the IRS for $10 billion, siding with intervenors who said a settlement to create an “anti-weaponization” fund tainted the case.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A federal judge on Friday temporarily blocked President Donald Trump’s ...

May 28 (Reuters) - IBM (IBM.N), opens new tab said on Thursday it plans to invest more than $10 billion in quantum computing over five years as it aims to build by 2029 the first large-scale quantum ...

Pima County plans to spend about $1.8 billion over the next year, while homeowners are likely to see slightly higher property tax bills. The Board of Supervisors approved the tentative budget for the ...

Eli Lilly has splashed up to $3.8 billion on an infectious disease pipeline, acquiring Curevo, LimmaTech Biologics and Vaccine Company to extend its buying spree into viral and bacterial pathogen R&D.